HIV disease progression among women following seroconversion during a tenofovir-based HIV prevention trial.

by Sharon A Riddler, Marla Husnik, Gita Ramjee, Anamika Premrajh, Bomkazi Onini Tutshana, Arendevi Pather, Samantha Siva, Nitesha Jeenarain, Gonasagrie Nair, Pearl Selepe, Samuel Kabwigu, Thesla Palanee-Phillips, Ravindre Panchia, Felix Mhlanga, Lisa Levy, Edward Livant, Karen Patterson, Vanessa Elharrar, Jennifer Balkus
Published 2017-01-01